Cartalax
Cartalax-related research explores cell renewal and stress responses. The cited work concerns tissue cultures; it does not establish the joint or cartilage benefits sometimes associated with its catalog name.
Animal references Senior Pro
AUREVIXSenior Pro
Compound reference
INFORMATIONAL REFERENCE
Senior Pro
This combination brings together Cartalax, Thymogen. Explore each component’s research focus below, followed by the evidence for the combination.
Research focus & potential applications
Thymogen
Thymogen is investigated in immune-cell signaling and blood-cell development. These early mechanistic questions differ from demonstrated prevention of illness or recovery benefits in an animal-care formula.
What the research shows
Explore the selected studies, their findings and their limits.
Cartalax
Read the findings & sources
Preclinical evidenceResearch on the AED peptide, also called T-31, in rat kidney tissue cultures reported changes in proliferation and apoptosis markers. This is evidence about cultured kidney cells, not a demonstration of cartilage repair or relief of canine arthritis. The cited study does not establish clinical joint outcomes in dogs.
Thymogen
Read the findings & sources
Preclinical evidenceA laboratory comparison of synthetic immune-related peptides examined blood-cell colony formation. Thymogen did not reproduce the stronger effect of the comparator peptide under the tested conditions. This illustrates why related thymic peptides are not interchangeable. Such experiments do not establish fewer infections or improved recovery in dogs.
Evidence for the combination
The sources above examine individual constituents or related molecules. They do not test this exact combination. A combined effect, improved recovery or greater safety cannot be inferred by adding the individual findings together.
What this means for dogs
The studies discussed here do not establish the safety or effectiveness of this catalog formula in dogs. Rat, mouse, cell-culture and human findings are not canine clinical results; they also do not establish absorption or effects from the listed oral formula.
For more information, contact info@aurevixpeptides.com.
Editorial review: September 23, 2026